Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[68Ga]Ga-FAPI PET/CT: The Dagnostic Accuracy for Primary Staging and Re-staging After Chemotherapy in Patients With Gastric and Gastro-esophageal Junctional Cancer

NCT05898854 is registered in ClinicalTrials.gov with Aalborg University Hospital as lead sponsor.

NCT NCT05898854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05898854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[68Ga]Ga-FAPI PET/CT: The Dagnostic Accuracy for Primary Staging and Re-staging After Chemotherapy in Patients With Gastric and Gastro-esophageal Junctional Cancer
Lead sponsor
Aalborg University Hospital
Phase
Phase 2
Overall status
Completed
Start date
February 15, 2024
Completion date
December 18, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, gastric cancer, gastro esophageal junctional cancer